Skip to content
Screener

Artivion AORT Q3 2025 earnings

Reported November 6, 2025 · After market close

Revenue$113.4MMiss by $3.0M
EPS$0.16Beat by $0.02
Revenue estimate$116.4M
EPS estimate$0.14

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$120.9M
EPS estimate$0.11

Financials

Q3 2025

Income statement

See full
Revenue$113.4M+18.4%
Gross profit$74.4M+21.9%
Operating income$12.5M+186%
Net income$6.5M+384%
EPS (diluted)$0.13+360%

Balance sheet

See full
Cash & equivalents$73.4M+30.7%
Total debt$262.0M-43.4%
Total equity$438.7M+44.0%
Total assets$857.7M+6.8%

Cash flow

See full
Operating cash flow$22.3M+94.3%
CapEx$4.6M+26.7%
Free cash flow$17.7M+126%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$2B+79.1%
Enterprise value$2.19B+43.6%
P/S4.7×+1.8×

Profitability

See full
Gross margin64.5%0.0pp
Operating margin6.1%-4.1pp
Net margin-2.2%-2.4pp

Returns & leverage

See full
Return on equity-2.5%-2.8pp
Debt / equity0.6×-0.9×
Current ratio3.9×+2.0×

Segments

By segment

See full
North America$58.3M+18.8%
EMEA$36.2M+19.1%
APAC$12.2M+18.0%
LATAM$6.6M+12.0%

By product

See full
Aortic stent grafts$39.6M+38.2%
On-X$26.8M+24.8%
Surgical sealants$18.9M+2.5%
Other$2.4M-11.0%

FAQ

When did Artivion report Q3 2025 earnings?
Artivion (AORT) reported Q3 2025 earnings on November 6, 2025 after market close.
What were Artivion's Q3 2025 revenue and EPS?
Artivion reported revenue of $113.4M and eps of $0.16 for Q3 2025.
Did Artivion beat estimates in Q3 2025?
Revenue missed the consensus estimate of $116.4M by $3.0M. EPS beat the consensus estimate of $0.14 by $0.02.
How did Artivion's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 18.4% from $95.8M a year earlier and eps grew 33.3% from $0.12.
Where can I find Artivion's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-050164) and the 10-Q periodic report (0001628280-25-050502) directly on SEC EDGAR. The filing index links above go to sec.gov.